Atika Capital Management’s Eli Lilly LLY Stock Holding History

Atika Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-23,000	Closed	-$1.85M	–	68
2016 Q3	$1.85M	Sell	23,000 -1,000	-4%	-$80K	0.75%	54
2016 Q2	$1.89M	Hold	24,000	–	–	0.81%	42
2016 Q1	$1.73M	Sell	24,000 -42,000	-64%	-$3.18M	1.04%	37
2015 Q4	$5.56M	Sell	66,000 -44,000	-40%	-$3.65M	2.86%	12
2015 Q3	$9.21M	Buy	110,000 +20,000	+22%	+$1.69M	4.51%	5
2015 Q2	$7.51M	Buy	+90,000	New	+$6.86M	3.38%	8

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Atika Capital Management's LLY Position: Q1 2026 in Review

Atika Capital Management held its Eli Lilly (LLY) position steady in Q1 2026 at 41,100 shares worth $37.8M. The position accounts for 4.75% of the portfolio, ranked #3.

Atika Capital Management first reported a position in LLY in Q3 2015 and has held it in 16 quarters since. The position peaked at $44.2M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Atika Capital Management held 41,100 shares of Eli Lilly worth $37.8M as of Q1 2026.
Atika Capital Management left its Eli Lilly share count unchanged in Q1 2026.
Eli Lilly made up 4.75% of Atika Capital Management's portfolio in Q1 2026, its #3 holding.
Atika Capital Management first reported a position in Eli Lilly in Q3 2015 and has held it in 16 quarters since.
Atika Capital Management's Eli Lilly position peaked at $44.2M in Q4 2025.
4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Atika Capital Management's 13F filing for Q1 2026, filed 14 May 2026.